Your browser does not support JavaScript
A Guide to Substance Abuse Services for Primary Care CliniciansTreatment Improvement Protocol (TIP) Series 24
Alldredge, B.I.; Lowenstein, D.H.; and Simon, R.P. Placebo-controlled trial of intravenous diphenylhydantoin for short-term treatment of alcohol withdrawal seizures. American Journal of Medicine 87: 645-648, 1989. Allen, J.P., and Litten, R.Z. Techniques to enhance compliance with disulfiram. Alcoholism: Clinical and Experimental Research 16: 1035-1041, 1992. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association, 1994. Anton, R.F., and Becker, H.C. Pharmacotherapy and pathophysiology of alcohol withdrawal. In: Kranzler, H.R., ed. Handbook of Experimental Pharmacology. Vol. 114, The Pharmacology of Alcohol Abuse. Berlin: Springer-Verlag, 1995. pp. 315-367. Apelt, S., and Emrich, H.M. Sodium valproate in benzodiazepine withdrawal [letter]. American Journal of Psychiatry 147(7): 950-951, 1990. Arndt, I.O.; Dorozynsky, L.; Woody, G.E.; McLellan, A.T.; and O'Brien, C.P. Desipramine treatment of cocaine dependence in methadone-maintained patients. Archives of General Psychiatry 49: 888-893, 1992. Arndt, I.O.; McLellan, A.T.; Dorozynsky, L.; Woody, G.E.; and O'Brien, C.P. Desipramine treatment for cocaine dependence: Role of antisocial personality disorder. Journal of Nervous and Mental Disease 182: 151-156, 1994. Baumgartner, G.R., and Rowen, R.C. Clonidine vs. chlordiazepoxide in the management of acute withdrawal syndrome. Archives of Internal Medicine 147: 1223-1226, 1987. Baumgartner, G.R., and Rowen, R.C. Transdermal clonidine versus chlordiazepoxide in alcohol withdrawal: A randomized, controlled clinical trial. Southern Medical Journal 84: 312-321, 1991. Bohn, M.J.; Kranzler, H.R.; Beazoglou, D.; and Staehler, B.A. Naltrexone and brief counseling to reduce heavy drinking. American Journal on Addictions 3(2): 91-99, 1994. Brewer, C. Controlled trials of Antabuse in alcoholism: The importance of supervision and adequate dosage. Acta Psychiatrica Scandinavica 86: 51-58, 1992. Center for Substance Abuse Treatment. State Methadone Treatment Guidelines. Treatment Improvement Protocol (TIP) Series, Number 1. DHHS Pub. No. (SMA) 93-1991. Washington, DC: U.S. Government Printing Office, 1993. Center for Substance Abuse Treatment. Detoxification from Alcohol and Other Drugs. Treatment Improvement Protocol (TIP) Series, Number 19. DHHS Pub. No. (SMA) 95-3046. Washington, DC: U.S. Government Printing Office, 1995a. Center for Substance Abuse Treatment. Matching Treatment to Patient Needs in Opioid Substitution Therapy. Treatment Improvement Protocol (TIP) Series, Number 20. DHHS Pub. No. (SMA) 95-3049. Washington, DC: U.S. Government Printing Office, 1995b. Chambless, D.L.; Cherney, J.; Caputo, G.C.; and Rheinstein, B.J.G. Anxiety disorders and alcoholism: A study with inpatient alcoholics. Journal of Anxiety Disorders 1: 29-40, 1987. Chance, J.F. Emergency department treatment of alcohol withdrawal seizures with phenytoin. Annals of Emergency Medicine 20: 520-522, 1991. Cox, B.J.; Norton, G.R.; Dorward, J.; and Fergusson, P.A. The relationship between panic attacks and chemical dependencies. Addictive Behaviors 14: 53-60, 1989. Croop, R.S.; Labriola, D.F.; Wroblewski, J.M.; and Nibbelink, D.W. A multicenter safety study of naltrexone as adjunctive pharmacotherapy for individuals with alcoholism. Abstract NR585. In: 1995 Annual Meeting: New Research Program and Abstracts. Washington, DC: American Psychiatric Association, 1995. Devenyi, P., and Harrison, M.L. Prevention of alcohol withdrawal seizures with oral diazepam loading. Canadian Medical Association Journal 132: 798-800, 1985. Duckert, F., and Johnsen, J. Behavioral use of disulfiram in the treatment of problem drinking. International Journal of Addictions 22: 445-454, 1987. Foy, A.; March, S.; and Drinkwater, V. Use of an objective clinical scale in the assessment and management of alcohol withdrawal in a large general hospital. Alcoholism: Clinical and Experimental Research 12: 360-364, 1988. Fuller, R.K.; Branchey, L.; Brightwell, D.R.; Derman, R.M.; Emrick, C.D.; Iber, F.L.; James, K.E.; Lacoursiere, R.B.; Lee, K.K.; Lowenstam, I.; Maany, I.; Neiderhiser, D.; Nocks, J.J.; and Shaw, S. Disulfiram treatment of alcoholism: A Veterans Administration cooperative study. Journal of the American Medical Association 256: 1449-1455, 1986. Gonzalez, J.P., and Brogden, R.N. Naltrexone: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence. Drugs 35: 192-213, 1988. Hayashida, M.; Alterman, A.I.; McLellan, T.; O'Brien, C.P.; Purtill, J.J.; Volpicelli, J.R.; Raphaelson, A.D.; and Hall, C.P. Comparative effectiveness and costs of inpatient and outpatient detoxification of patients with mild-to-moderate alcohol withdrawal syndrome. New England Journal of Medicine 320: 358-365, 1989. Hurt, R.D.; Offord, K.P.; Croghan, I.T.; Gomez-Dahl, L.; Kottke, T.E.; Morse, R.M.; and Melton,L.J. III. Mortality following inpatient addictions treatment: Role of tobacco use in a community-based cohort. Journal of the American Medical Association 275(14): 1097-1103, 1996. Keane, T.M.; Foy, D.W.; Nunn, B.; and Rychtarik, R.G. Spouse contracting to increase Antabuse compliance in alcoholic veterans. Journal of Clinical Psychology 40: 340-344, 1984. Kosten, T.R.; Morgan, C.M.; Falcione, J.; and Schottenfeld, R.S. Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine. Archives of General Psychiatry 49: 894-898, 1992. Kranzler, H.R.; Burleson, J.A.; Del Boca, F.K.; Babor, T.F.; Korner, P.; Brown, J.; and Bohn, M.J. Buspirone treatment of anxious alcoholics. Archives of General Psychiatry 51: 720-731, 1994. Kraus, M.L.; Gottlieb, L.D.; Horwitz, R.I.; and Anscher, M. Randomized clinical trial of atenolol in patients with alcohol withdrawal. New England Journal of Medicine 313: 905-909, 1985. Kristenson, H. Long-term Antabuse treatment of alcohol-dependent patients. Acta Psychiatrica Scandinavica 86: 41-45, 1992. Ling, W., and Wesson, D.R. Naltrexone treatment for addicted health-care professionals: A collaborative private practice experience. Journal of Clinical Psychiatry 45(9 Pt 2): 46-48, 1984. Liskow, B.I.; Rinck, C.; Campbell, J.; and DeSouza, C. Alcohol withdrawal in the elderly. Journal of Studies on Alcohol 50(5): 414-421, 1989. Mason, B.J.; Kocsis, J.H.; Ritvo, E.C.; and Cutler, R.B. A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression. Journal of the American Medical Association 275: 761-767, 1996. Mayo-Smith, M.F., and Bernard, D. Late-onset seizures in alcohol withdrawal. Alcoholism: Clinical and Experimental Research 19(3): 656-659, 1995. McGrath, P.J.; Nunes, E.V.; Stewart, J.W.; Goldman, D.; Agosti, V.; Ocepek-Welikson, K.; and Quitkin, F.M. Imipramine treatment of alcoholics with primary depression: A placebo-controlled clinical trial. Archives of General Psychiatry 53: 232-240, 1996. Mueller, T.I.; Goldenberg, I.M.; Gordon, A.L.; Keller, M.B.; and Warshaw, M.G. Benzodiazepine use in anxiety disordered patients with and without a history of alcoholism. Journal of Clinical Psychiatry 57: 83-89, 1996. Novick, D.M.; Pascarelli, E.M.; Joseph, H.; Salsitz, E.A.; Richman, B.L.; Des Jarlais, D.C.; Anderson, M.D.; Dole, V.P.; and Nyswander, M.E. Methadone maintenance patients in general medical practice: A preliminary report. Journal of the American Medical Association 259: 3299-3302, 1988. O'Connor, P.G.; Waugh, M.E.; Carroll, K.M.; Rounsaville, B.J.; Diagkogiannis, I.A.; and Schottenfeld, R.S. Primary-care-based ambulatory opioid detoxification: The results of a clinical trial. Journal of General Internal Medicine 10: 255-260, 1995. O'Farrell, T.J., and Bayog, R.D. Antabuse contracts for married alcoholics and their spouses: A method to maintain Antabuse ingestion and decrease conflict about drinking. Journal of Substance Abuse Treatment 3: 1-8, 1986. O'Malley, S.S.; Jaffe, A.J.; Chang, G.; Rode, S.; Schottenfeld, R.; Meyer, R.E.; and Rounsaville, B. Six-month follow-up of naltrexone and psychotherapy for alcohol dependence. Archives of General Psychiatry 53: 217-224, 1996. O'Malley, S.S.; Jaffe, A.J.; Chang, G.; Schottenfeld, R.S.; Meyer, R.E.; and Rounsaville, B. Naltrexone and coping skills therapy for alcohol dependence: A controlled study. Archives of General Psychiatry 49: 881-887, 1992. Rosebush, P.I., and Mazurek, M.F. Catatonia after benzodiazepine withdrawal. Journal of Clinical Psychopharmacology 16(4): 315-319, 1996. Rothstein, E. Prevention of alcohol withdrawal seizures: The roles of diphenylhydantoin and chlordiazepoxide. American Journal of Psychiatry 130: 1381-1432, 1973. Roy-Byrne, P.P.; Ward, N.G.; and Donnelly, P.J. Valproate in anxiety and withdrawal syndromes. Journal of Clinical Psychiatry 50: 44-48, 1989. Saitz, R.; Mayo-Smith, M.F.; Friedman, L.S.; and Calkins, D.R. Nationwide practice patterns in the treatment of alcohol withdrawal. Clinical Research 41: 549A, 1993. Saitz, R.; Mayo-Smith, M.F.; Roberts, M.S.; Redmond, H.A.; Bernard, D.R.; and Calkins, D.R. Individualized treatment for alcohol withdrawal. Journal of the American Medical Association 272: 519-523, 1994. Sampliner, R., and Iber, F.L. Diphenylhydantoin control of alcohol withdrawal seizures. Journal of the American Medical Association 230: 1430-1432, 1974. Schnoll, S.H. Drug abuse, overdose and withdrawal syndromes. In: Ayres, S.M.; Grenik, A.; Holbrook, P.R.; and Shoemaker, W.C., eds. The Text Book of Critical Care, 3rd ed. Philadelphia, PA: W.B. Saunders Co., 1995. pp. 1176-1186. Sellers, E.M.; Naranjo, C.A.; Harrison, M.; Devenyi, P.; Roach, C.; and Sykora, K. Diazepam loading: Simplified treatment of alcohol withdrawal. Clinical Pharmacology Therapy 34: 822-826, 1983. Sullivan, J.T.; Sykora, K.; Schneiderman, J.; Naranjo, C.A.; and Sellers, E.M. Assessment of alcohol withdrawal: The revised Clinical Institute Withdrawal Assessment for Alcohol scale (CIWA-Ar). British Journal of Addiction 84: 1353-1357, 1989. Volpicelli, J.R.; Alterman, A.I.; Hayashida, M.; and O'Brien, C.P. Naltrexone in the treatment of alcohol dependence. Archives of General Psychiatry 49: 876-887, 1992. Wartenberg, A.A.; Nirenberg, T.D.; Liepman, M.R.; Silvia, L.Y.; Begin, A.M.; and Monti, P.M. Detoxification of alcoholics: Improving care by symptom-triggered sedation. Alcoholism: Clinical and Experimental Research 14: 71-75, 1990. Wesson, D.R. Revival of medical maintenance in the treatment of heroin dependence [editorial]. Journal of the American Medical Association 259(22): 3314-3315, 1988. Wetterling, T.; Kanitz, R.D.; Veltrup, C.; and Driessen, M. Clinical predictors of alcohol withdrawal delirium. Alcohol: Clinical and Experimental Research 18: 1100-1102, 1994. Wiehl, W.O.; Hayner, G.; and Galloway, G. Haight Ashbury Free Clinics' drug detoxification protocols -- Part 4: Alcohol. Journal of Psychoactive Drugs 26(1): 57-59, 1994. Wright, C.; Vafier, J.A.; and Lake, C.R. Disulfiram-induced fulminating hepatitis: Guidelines for liver panel monitoring. Journal of Clinical Psychiatry 49: 430-434, 1988.
Site Map
Help
Account
Cart
Home
